- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x PRO: PROLINE(Non-covalent)
- 20 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)
P6G.2: 7 residues within 4Å:- Chain A: D.56, Y.57, P.64, F.65, C.66
- Ligands: P6G.5, P6G.8
Ligand excluded by PLIPP6G.3: 4 residues within 4Å:- Chain A: G.11, T.12
- Chain B: A.21
- Ligands: P6G.6
Ligand excluded by PLIPP6G.4: 4 residues within 4Å:- Chain A: L.83, A.84, E.87, S.88
Ligand excluded by PLIPP6G.5: 5 residues within 4Å:- Chain A: F.58, V.59, P.64, F.65
- Ligands: P6G.2
Ligand excluded by PLIPP6G.6: 10 residues within 4Å:- Chain A: I.7, E.8, G.11, T.12, W.15
- Chain B: A.21, D.22, T.23, F.25
- Ligands: P6G.3
Ligand excluded by PLIPP6G.7: 2 residues within 4Å:- Chain A: S.88, R.135
Ligand excluded by PLIPP6G.8: 5 residues within 4Å:- Chain A: P.64, F.65, C.66, R.135
- Ligands: P6G.2
Ligand excluded by PLIPP6G.12: 8 residues within 4Å:- Chain B: E.107, P.108, A.117, R.118, R.119, N.129, E.131, E.142
Ligand excluded by PLIPP6G.13: 9 residues within 4Å:- Chain B: V.63, S.88, L.89, A.91, D.94, P.134, R.135, P.137, T.138
Ligand excluded by PLIPP6G.14: 7 residues within 4Å:- Chain A: D.16, K.31
- Chain B: V.19, Y.20, K.29, K.31, E.39
Ligand excluded by PLIPP6G.16: 7 residues within 4Å:- Chain C: D.56, Y.57, P.64, F.65, C.66
- Ligands: P6G.19, P6G.22
Ligand excluded by PLIPP6G.17: 4 residues within 4Å:- Chain C: G.11, T.12
- Chain D: A.21
- Ligands: P6G.20
Ligand excluded by PLIPP6G.18: 4 residues within 4Å:- Chain C: L.83, A.84, E.87, S.88
Ligand excluded by PLIPP6G.19: 5 residues within 4Å:- Chain C: F.58, V.59, P.64, F.65
- Ligands: P6G.16
Ligand excluded by PLIPP6G.20: 10 residues within 4Å:- Chain C: I.7, E.8, G.11, T.12, W.15
- Chain D: A.21, D.22, T.23, F.25
- Ligands: P6G.17
Ligand excluded by PLIPP6G.21: 2 residues within 4Å:- Chain C: S.88, R.135
Ligand excluded by PLIPP6G.22: 5 residues within 4Å:- Chain C: P.64, F.65, C.66, R.135
- Ligands: P6G.16
Ligand excluded by PLIPP6G.26: 8 residues within 4Å:- Chain D: E.107, P.108, A.117, R.118, R.119, N.129, E.131, E.142
Ligand excluded by PLIPP6G.27: 9 residues within 4Å:- Chain D: V.63, S.88, L.89, A.91, D.94, P.134, R.135, P.137, T.138
Ligand excluded by PLIPP6G.28: 7 residues within 4Å:- Chain C: D.16, K.31
- Chain D: V.19, Y.20, K.29, K.31, E.39
Ligand excluded by PLIP- 4 x NA: SODIUM ION(Non-functional Binders)
NA.10: 6 residues within 4Å:- Chain A: W.15, D.16, L.18
- Chain B: W.15, D.16, L.18
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:L.18, B:L.18, B:L.18
NA.11: 2 residues within 4Å:- Chain B: H.164, W.166
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:H.164
NA.24: 6 residues within 4Å:- Chain C: W.15, D.16, L.18
- Chain D: W.15, D.16, L.18
3 PLIP interactions:1 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:L.18, C:L.18, C:L.18
NA.25: 2 residues within 4Å:- Chain D: H.164, W.166
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:H.164
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hodson, C. et al., Structural Analysis of Human Fancl, the E3 Ligase in the Fanconi Anemia Pathway. J.Biol.Chem. (2011)
- Release Date
- 2011-07-20
- Peptides
- E3 UBIQUITIN-PROTEIN LIGASE FANCL: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x PRO: PROLINE(Non-covalent)
- 20 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)
- 4 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hodson, C. et al., Structural Analysis of Human Fancl, the E3 Ligase in the Fanconi Anemia Pathway. J.Biol.Chem. (2011)
- Release Date
- 2011-07-20
- Peptides
- E3 UBIQUITIN-PROTEIN LIGASE FANCL: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B